All In Biotech

Drug Trial Radar · NCT00710788

Reduce Cardiovascular Calcifications to Reduce QT Interval in Dialysis

Interventional, Multicenter, Prospective, Randomized Trial to Slow Down the Progression of Cardiovascular Calcifications to Reduce QTd in Incident Dialysis Patients

Last checked: Nov 20, 2026Latest source record: Feb 12, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

360

Actual

Start

Jan 2007

Primary completion

Sep 2010

Study completion Sep 2011

Sponsor

Lead sponsor
Azienda Sanitaria ASL Avellino 2Academic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 4, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Research proposal to evaluate the impact of different phosphate binders on the progression of cardiovascular calcification and QT dispersion in new haemodialysis patients.

Conditions

  • Cardiovascular Mortality

Interventions

  • sevelamer phosphate-bindersDrug

    1600 mg/day for 2 years

  • Calcium CarbonateDrug

    Calcium carbonate 1 g/day for 2 years

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. death due to cardiac arrhythmias or as sudden cardiac death defined as any deaths coded as "cardiac arrest, cause unknown" or "cardiac arrhythmia" without any exclusionsTime frame: 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nephrology Division

    Solofra, Avellino, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.